Cerina Dubois, Julie Bobitt, Lei Ding, Dean T Eurich, Ashley Knapp, Neil Jordan
{"title":"Medical Cannabis and Psychological Well-being in Illinois' Opioid Alternative Pilot Program.","authors":"Cerina Dubois, Julie Bobitt, Lei Ding, Dean T Eurich, Ashley Knapp, Neil Jordan","doi":"10.1016/j.amepre.2025.107941","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>In Illinois, the Opioid Alternative Pilot Program (OAPP) was implemented to provide individuals access to medical cannabis as a direct substitute for opioids. Despite medical cannabis being frequently used for mental health symptoms, little is known about medical cannabis' role on overall psychological well-being (PWB). Hence, the objective of this study is to examine the association of medical cannabis use with PWB among the first OAPP cohort.</p><p><strong>Methods: </strong>A survey was sent from February-July 2019 to those who enrolled in the OAPP. Cannabis users (n=626) were compared to non-users (n=234) to determine whether there was an association between cannabis use within the past year and PWB. PWB was measured on a scale of 1 to 5 (\"1\" being \"Poor\"; and \"5\" being \"Excellent\"). Backwards stepwise regression models were used. Sensitivity analysis was also conducted to determine whether there was an association between 'regular cannabis use' (using 3 or more times a week) versus 'no cannabis use'.</p><p><strong>Results: </strong>The study sample included 860 participants. The average age was 47 years (SD 14.2); 60% of the cohort was male; 72% were not of Hispanic, Latino, or Spanish origin; 67% were married, and 67% of cannabis users reported having a disability. The average perceived PWB was 3.18 (SD 0.94) ('Good') with no statistically significant difference in PWB between the two groups (users: 3.21 (SD 1.01); non-users: 3.12 (SD 0.71); p=0.18).</p><p><strong>Conclusion: </strong>In this cohort of OAPP participants, there was no clinically meaningful difference in PWB between cannabis users and non-users.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"107941"},"PeriodicalIF":4.3000,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Preventive Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amepre.2025.107941","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: In Illinois, the Opioid Alternative Pilot Program (OAPP) was implemented to provide individuals access to medical cannabis as a direct substitute for opioids. Despite medical cannabis being frequently used for mental health symptoms, little is known about medical cannabis' role on overall psychological well-being (PWB). Hence, the objective of this study is to examine the association of medical cannabis use with PWB among the first OAPP cohort.
Methods: A survey was sent from February-July 2019 to those who enrolled in the OAPP. Cannabis users (n=626) were compared to non-users (n=234) to determine whether there was an association between cannabis use within the past year and PWB. PWB was measured on a scale of 1 to 5 ("1" being "Poor"; and "5" being "Excellent"). Backwards stepwise regression models were used. Sensitivity analysis was also conducted to determine whether there was an association between 'regular cannabis use' (using 3 or more times a week) versus 'no cannabis use'.
Results: The study sample included 860 participants. The average age was 47 years (SD 14.2); 60% of the cohort was male; 72% were not of Hispanic, Latino, or Spanish origin; 67% were married, and 67% of cannabis users reported having a disability. The average perceived PWB was 3.18 (SD 0.94) ('Good') with no statistically significant difference in PWB between the two groups (users: 3.21 (SD 1.01); non-users: 3.12 (SD 0.71); p=0.18).
Conclusion: In this cohort of OAPP participants, there was no clinically meaningful difference in PWB between cannabis users and non-users.
期刊介绍：
The American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health.
Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women''s health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
